SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Eiko Lifesciences informs about change in management

26 May 2026 Evaluate
Eiko Lifesciences has informed that based on the recommendation of the Audit Committee, the Board of Directors of the Company has at its Meeting held today i.e. on 26th May, 2026, has approved the appointment of NP Rajput & Co as Internal Auditor for FY 2026-27. Disclosure of information pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 (‘SEBI Circular’) is attached as Annexure-A.

The above information is a part of company’s filings submitted to BSE. 

Eiko Lifesciences Share Price

51.51 -1.59 (-2.99%)
10-Jun-2026 16:59 View Price Chart
Peers
Company Name CMP
SRF 2732.95
BASF India 3291.00
Tata Chemicals 719.95
Pidilite Inds. 1503.95
Deepak Nitrite 1666.80
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×